Boston-based PhaseV, which is developing AI software to accelerate clinical trials and drug development, raised a $50M Series A co-led by Accel and Insight
Summary by Techmeme
1 Articles
1 Articles
All
Left
Center
Right
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage